MedTrace Logo

Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery

NCT02067884 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2019-01-25

No results posted yet for this study

Summary

This pilot clinical trial studies contrast enhanced ultrasound and shear wave elastography in measuring response in patients with breast cancer receiving chemotherapy before surgery. New imaging procedures, such as contrast enhanced ultrasound and shear wave elastography, may predict treatment response earlier and more accurately than contrast enhanced magnetic resonance imaging.

Conditions

Interventions

PROCEDURE

dynamic contrast-enhanced ultrasound imaging

Undergo CEUS

PROCEDURE

shear wave elastography

Undergo SWE

DRUG

Definity, (Lipid Microspheres) Intravenous Suspension

Participant will receive contrast agent by intravenous administration

DEVICE

Philips Shear Wave Elastography

Equipment used for SWE

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • L K Whittier Foundation

    collaborator UNKNOWN

  • University of Southern California

    lead OTHER

Principal Investigators

  • Linda Hovanessian-Larsen · University of Southern California

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-19
Primary Completion
2016-09-25
Completion
2016-09-25
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02067884 on ClinicalTrials.gov